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Riassunto
La Malattia policistica renale è una malattia autosomica ereditaria del gatto riscontrata per 
lo più in quelli di razza persiana. Le cisti renali possono essere rilevate con esame ecografico 
su gatti a partire dalla 16ma settimana di vita. Questo studio ha avuto 3 obiettivi: verificare se 
la malattia è presente nei gatti persiani serbi, valutare l’efficienza diagnostica dell’ecografia 
confrontandola con i test genetici, monitorare i parametri ematologici e biochimici. Settanta 
gatti di razza persiana, di età compresa tra 4 mesi e 8 anni, sono stati sottoposti ad esame 
ecografico renale, emocromo completo e analisi dei parametri biochimici. La PCR-RFLP 
effettuata su tamponi del cavo orale ha permesso di rilevare la presenza della mutazione 
sull'esone 29 caratteristica della malattia nel 48,6% dei gatti esaminati, a differenza dell’esame 
ecografico che ha rilevato positività solo per il 18,6% dei felini. Il range di età degli animali 
risultati positivi alla PCR-RFLP e negativi all’esame ecografico varia da 4 mesi a 3,5 anni. In 
tutti i gatti esaminati i valori dei parametri ematologici e biochimici non si sono discostati 
dai valori normali. Il test genetico è risultato il più attendibile per la diagnosi precoce della 
malattia nei gatti persiani. L’analisi del DNA può essere impiegata fin dalla nascita escludendo, 
di conseguenza, il ricorso ad altre procedure diagnostiche.
Prima segnalazione sulla presenza della
Malattia policistica renale in gatti di razza persiana in Serbia
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Summary
Polycystic kidney disease (PKD) is an inherited autosomal disorder in cats, mostly diagnosed 
in Persian cats. Renal cysts can be diagnosed by ultrasound, but cats must be at least 16 weeks 
old. The goals of this study were to assess the occurrence of PKD in Serbia using a randomly 
selected group of Persian cats, to compare the diagnostic efficacy of ultrasound and genetic 
tests, and to measure haematological and selected biochemical parameters. We examined 
70 cats of Persian breed, between 4 months and 8 years of age. Complete blood count and 
selected biochemical parameters were measured, renal ultrasound was performed. Swabs of 
the oral cavity were obtained for genetic testing. Percentage of PKD positive cats identified 
by genetic testing was 48.6%, whilst only 18.6% were detected through ultrasound. Animals 
that were polymerase chain reaction‐restriction fragment length polymorphism (PCR-RFLP) 
positive and ultrasound negative ranged from 4 months to 3.5 years. All haematological 
and biochemical parameters were within the the normal range values in all examined cats. 
Genetic methods proved to be the most effective for reliable and early diagnosis of PKD 
in Persian cats. DNA analysis can be used right after birth, and excludes the need for other 
diagnostic procedures, such as ultrasound.
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Seven weeks is considered the earliest time to detect 
cysts using ultrasound and the sensitivity of this 
method in cats is 75% at 16 weeks of age, and 91% 
at 36 weeks of age (Bonazzi et  al. 2009). However, 
when it comes to older cats, ultrasonography is a 
very practical non-invasive method to diagnose PKD 
(Bonazzi et  al. 2009). High frequency transducers 
are required (from 7 MHz or higher) to detect 
cysts on ultrasound, cysts in the cortex are easily 
detected because the medulla is hypoechoic 
(Domanjko-Petrič et al. 2008). Cats should be at least 
10 months old to claim that they are negative on 
ultrasound (Barrs et al. 2011).
Lyons and colleagues (Lyons et  al. 2004) were the 
first to describe a molecular tool for detecting the 
mutation responsible for the development of cysts. 
Since then, there have been numerous papers 
aiming at developing more specific and more 
sensitive molecular methods for the diagnosis of the 
causes of PKD (Young et al. 2006, Helps et al. 2007, 
Son et al. 2008, Bonazzi et al. 2009, Lee et al., 2010).
The goals of this study was to analyse the frequency 
of PKD in group of randomly selected Persian cats 
from Serbia, and to evaluate the sensitivity and 
specificity of renal ultrasound and genetic tests in 
this population. Haematological and biochemical 
parameters (urea, creatinine, and phosphorus) as 
indicators of renal function were also examined. To 
the best of our knowledge, this is the first study in 
the Republic of Serbia focusing on the occurrence of 
PKD in Persian cats. 
Materials and methods
The study included 70 cats of Persian breed 
originating from breeders and individual owners 
(44  females and 26 males). Tested cats were not 
related and were from different parts of Serbia. The 
age of the cats ranged from 4 months to 8 years. 
In addition to haematological and biochemical 
analyses, kidneys of all cats were examined for the 
presence of cysts by ultrasound, whilst the presence 
of mutation on exon 29 was investigated by DNA 
analysis using polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP). No 
urinalysis was performed.
Blood was collected by venepucture of v. cephalica 
antebrachii dextra in vacutainers with anticoagulant 
(EDTA) for complete blood count, and in vacutainers 
without anticoagulant for biochemical analysis. For 
haematological analysis IDEXX ProCyte Dx was used 
(IDEXX Laboratories, Westbrook, Maine, USA), and for 
biochemical analysis (urea, creatinine, phosphorus) 
IDEXX VetTest 8008 was used (IDEXX Laboratories, 
Westbrook, Maine, USA).
For ultrasound, animals were examined in dorsal 
Introduction
The first published data about Polycystic kidney 
disease (PKD) appeared in 1969 (Barrs et  al. 2011). 
Polycystic kidney disease is one of the most frequent 
causes of death in Persian cats (Egenvall et al. 2009). 
Similar clinical and morphological characteristics 
between Persian cats and humans suggest that cats 
could be useful models for the examination of the 
same ailment in human beings (Eaton et  al. 2009, 
Aleksic-Kovacevic et al. 2010).
Polycystic kidney disease is an inherited disease in 
Persian cats and related breeds (Exotic Shorthairs 
and Himalayan cats) (Grahn et al. 2004, Lyons et al. 
2004, Helps et al. 2007, Lyons 2010), the disease has 
a global prevalence of 37% (Di Bartola 2000). The 
genetic mutation causing PKD was identified in 
the PKD1 gene. This gene encodes a protein called 
polycystin-1, located on the 16th pair of autosomes. 
Mutation consists of a transversion of CA, which 
induces a stop codone at the position 3284 on the 
exon 29, leading to the loss of 25% of the C-terminus 
of polycystin-1 (Lyons et al. 2004). This is a dominant 
autosomal nonsense point mutation, which causes 
foetal (Lee Ya-Jane et al. 2010) and neonatal (Barrs 
et  al. 2011) death in homozygous cats, hence 
the disease can be clinically manifested only in 
heterozygous animals. Polycystic kidney disease is 
characterized by the formation of cysts of different 
sizes (from 1 mm to more than 1 cm) in cortex and 
medulla of kidneys, liver, and pancreas (De Cock et al. 
2007). The number of cysts in a kidney may vary from 
1 to more than 200 (Domanjko-Petrič et  al. 2008). 
Cats with PKD usually show clinical signs of disease 
after the age of 7 years (Domanjko-Petrič et al. 2008, 
Son et al. 2008). In those cases in which cats do not 
show any clinical signs of kidney failure, we can still 
assess the general status of the animal as well as 
its renal function by monitoring of haematological 
and other biochemical parameters – such as urea, 
creatinine and phosphorus. Clinical sings, such as 
anorexia, vomiting, and polyuria, manifest when 
more than 70% of kidneys is no longer functional. 
For this reason an adequate diagnosis should be 
done as early as possible, especially in predisposed 
breeds (Lyons 2010), so to identify cats with PKD 
in time and prevent them from having offspring 
and transmit the disease (Criado-Fornelio et  al. 
2008). The cysts are present from birth, but they 
are smaller in younger cats (Domanjko-Petrič et al. 
2008). Although it is recommended that breeders 
should not mate cats with PKD, this advice is often 
not taken. Reasons for non-compilance include: 
absence of clinical signs, lack of information about 
the disease, expensive or unavailable diagnostic 
analysis, and the fact that decisions about breeding 
are made before the results of the analysis arrive 
(Lyons 2010).
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Ultrasound
The cysts in the kidneys were spherical, anechoic or 
hypoechoic cavities (Figure 1). Cysts were detected 
in the renal parenchyma of 13 of 70 cats (18.6%; 
10 females and 3 males). The largest number of 
cysts was located in the cortex of the kidneys. The 
youngest cat with PKD was 3.5 years old.
PCR ‑ RFLP
Polymerase chain reaction‐restriction fragment 
length polymorphism resulted in only 1 fragment of 
559 bp on agarose gel in samples from cats without 
the PKD mutation, while samples from cats with the 
PKD mutation produced 2 more fragments of 316 bp 
and 243 bp (Figure 2). The results revealed 34 PKD 
affected individuals (23 females and 11  males) 
representing 48.6% of considered cats  (Table I). 
Genetic analysis confirmed the presence of mutation 
causing the disease for all 13 cats resulted positive 
for PKD on ultrasound. The age of these animals 
ranged from 4 months to 8 years. It is important to 
stress that the 21 cats which ranged from 4 months 
to 3.5  years, were found to be PKD positive by 
PCR-RFLP analysis, although no signs of PKD were 
detected on ultrasound.
Discussion
Polycystic kidney disease is one of the most common 
genetic diseases in cats, which may lead to death 
(Egenvall et al. 2009). Mutation causing PKD is very 
common in Persian cats and related breeds, reaching 
the frequency of 40%. There is no therapy for this 
disease, so prevention is crucial. Prevention could 
be achieved by exclusion of PKD positive individuals 
from reproduction and this requires reliable 
diagnostic tools such as PCR-RFLP able to detect PKD 
in early stages of life (Criado-Fornelio et al. 2008).
position, both kidneys were examined. Aloka 
ProSound 5000 SSD (Hitachi Aloka Medical, Tokyo, 
Japan) with 10 MHz linear transducer and 7 MHz 
convex transducer were used. 
For PCR-RFLP detection, DNA was isolated from 
oral cavity swabs using KAPA Express Extract Kit 
(Kapa Biosystems, Wilmington, Massachusetts, 
USA; PN KK7152) following the manufacturer's 
protocol. Samples were kept at a temperature 
of -20°C. The following set of primers was used 
for the amplification of PKD exon 29: PKD1F 
(3’  CAGGTAGACGGGATAGACGA  5’) and PKD2R 
(3’  TTCTTCCGTGTCAACGACTG  5’) by Lyons and 
colleagues (Lyons et  al. 2004). The amplification 
was conducted in 25 μl reaction volume containing 
12.5 μl of KAPA2G Robust HotStart ReadyMix (Kapa 
Biosystems, Wilmington, Massachusetts, USA; PN 
KK7152) and 1.25  μl of each primer from PKD1F / 
PKD2R primer set and 10 μl DNA sample. Thermal 
protocol recommended for KAPA2G Robust HotStart 
ReadyMix was used: 3 minutes of initial denaturation 
at 94°C, followed by 35 cycles of denaturation 
(30 seconds at 94°C), primer annealing (30 seconds 
at 55°C), extension (1 minute at 72°C) and a final 
extension step at 72°C, which lasted 1 minute. 
Ten microliters of PCR product was digested with 
10U of SchI (MlyI) (New England Biolabs, Ipswich, 
Massachusetts, USA) in a 30 µl reaction containing 
1x Buffer Tango. Digestion performed at 37° for 
12 hours was followed by inactivation of the enzyme 
at 65°C for 20 minutes. 
The PCR products were visualised with UV light after 
staining the 2% agarose gel with ethidium bromide 
using commercial O'RangeRulerTM 100  bp DNA 
Ladder (Fermentas, Waltham, Massachusetts, USA).
Formalin fixed paraffin embedded (FFPE) liver 
sample obtained from a PKD positive cat was used as 
a positive control for PCR. DNA isolated from a buccal 
swab obtained from a 10-year old PKD negative 
domestic cat was used as a negative control.
Results
Haematological and biochemical 
parameters
Haematological parameters in all examined 
cats were within the normal range. Biochemical 
parameters (urea, creatinine, and phosphorus) in 
all cats were also within reference intervals (normal 
ranges of analyzer were 5.7-12.9 mmol/l for urea, 
71-212 µmol/l for creatinine and 1-2.42 mmol/l 
for phosphorus). The mean values of urea in PKD 
positive cats were 7.5 mmol/l, creatinine 103 µmol/l 
and phosphorus 2.05 mmol/l. Figure 1. Ultrasound findings of cysts in the kidney.
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were within reference ranges in all PKD positive 
cats. Haematology results indicated good health, 
and the number of erythrocytes, leukocytes, and 
thrombocytes was normal in all animals. Mean 
values of urea (7.5 mmol/l), creatinine (103 µmol/l) 
and phosphorus (2.05 mmol/l) were in accordance 
with reference values and literature data (Bosje et al. 
1998). That could be explained by the fact that clinical 
signs, symptoms and health issues occur in older 
individuals (Barrs et al. 2011), and most of cats in our 
study were younger than 5 years. Domanjko-Petrič 
and colleagues (Domanjko-Petrič et al. 2008) found 
higher levels of creatinine in 10 cats with the disease, 
but their average age was 12 years. These findings 
suggest that haematological and biochemical 
parameters may be within reference interval in PKD 
positive individuals, especially in young ones.
For every patient involved in this study PKD was 
diagnosed by ultrasound, the findings were then 
confirmed by DNA analysis showing the underlying 
mutation. However, in 21 animals (the youngest 
was 4 months and the oldest was 1.5 year old) the 
presence of mutation was found by the molecular 
genetic method, while the presence of cysts was 
not observed on ultrasound. The cause of this may 
be that cysts in younger cats are so small that they 
cannot be visualized by ultrasound. Therefore, it 
is reasonable to recommend molecular genetic 
methods for PKD detection if a cat is younger than 
3  months (Domanjko-Petrič et  al. 2008). Some 
authors suggest that DNA analysis is the only method 
for PKD diagnostic in cats younger than 10 months 
(Barrs et al. 2011), as with DNA testing it is possible 
to detect the mutations at a very early age –  right 
after birth. In contrast to that, PKD diagnostic 
by ultrasound require constant monitoring of 
appearance and progression of cysts. Nonetheless, 
ultrasound allows for assessing the size, shape, and 
location of the kidneys and may also be used to assess 
renal blood flow (Platt 1997). Besides, if compared to 
the preparation for ultrasound, sampling (swab) for 
DNA analyses is much easier and the discomfort of 
individuals is considerably smaller. 
Cysts are present right after birth, but clinical 
symptoms usually manifest in older animals 
because the growth of cysts increases pressure on 
renal parenchyma, leading to renal insufficiency 
(Domanjko-Petrič et  al. 2008). The moment of 
manifestation of signs and symptoms varies over a 
period ranging from 3 to 10 years (Barrs et al. 2011). 
In this study, DNA analysis using PCR-RFLP method 
revealed the mutation causing PKD in 34 animals 
(48.6%). In 21 cats (30%), the disease was diagnosed 
only using PCR-RFLP (cysts were not found by 
ultrasound). Cysts were found by ultrasound only 
in 13 cats (18.6%). The PKD frequency found in this 
study is higher than the one reported in USA (where 
20% of cats resulted positive) (Lyons et  al. 2004), 
Slovenia (36%) (Domanjko-Petrič et  al. 2008), Italy 
(41.1%) (Bonazzi et al. 2009), France (41.8%) (Barthez 
et al. 2003), and results estimated on the global level 
also (37%) (Di Bartola 2000). However, these results 
are similar to those in Great Britain (49.2%) (Cannon 
et  al. 2001) and Australia (45%) (Barrs et  al. 2011). 
Estimates assess that about 6% of cats in USA have 
PKD, which makes it the most common inherited 
disorder in cats (Lyons et al. 2004).
Among the cats we analysed, females were more 
affected by PKD than males (52.3% vs. 42.3%). Yet 
the small number of samples limits us from asserting 
whether this disease is more frequent in females; still 
our results are consistent with data from the literature 
(Barrs et al. 2011, Domanjko-Petrič et al. 2008).
In this study, haematology and selected biochemical 
parameters (urea, creatinine, and phosphorus) 
Figure 2. Ethidium bromide stained agarose gel showing amplification products of exon 29 after digestion. PKD negative cats will produce just one 
fragment (559 bp) of the wild-type allele and PKD positive cats will produce two more bands (316 bp and 243 bp). M = Ladder; 1 = Positive control 
(PKD positive cat); 2-13 = Sampled cats; 14 = Negative control (PKD negative cat).
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 M
500 bp
300 bp
500 bp
300 bp
Table I. Ultrasound and molecular detection using PCR of PKD in Persian 
cats of different sexes.
Gender Number of samples
Prevalence N(%)
Ultrasonography PCR
Male 26 3 11
Female 44 10 23
Total 70 13 (18.6) 34 (48.6)
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In conclusion, molecular genetic methods are the 
most efficient and reliable for timely diagnosis of 
PKD and can be used from the first day of life. Also, 
sampling for genetic tests involves significantly 
lower stress levels for the animal than ultrasound. 
Furthermore, genetic tests take considerably 
less time compared to procedures required for 
haematological and biochemical analyses or 
ultrasound. DNA tests for the mutation causing PKD 
should be done on all Persian cats, before owners 
and breeders decide to include them in reproduction 
(Young et al. 2004). Finally, as breeders usually make 
breeding strategy even before tests are taken, it 
is important to offer them continuing education, 
aimed at preventing the disease spreading and 
providing longer, more comfortable lives to cats.
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